 |
A
call for sponsorship to support the running and future development
of Glycosmedia |
| |
Click on the above headline for an overview
of the Glycosmedia diabetes news service and our call for sponsorship.
Brief details on how sponsorship will work can be seen here. For further details please contact (Jim Young, Editor-in-Chief) |
| |
|
|
Annual
Professional Conference 2009 |
| |
Our flagship annual event for healthcare professionals
working in the field of diabetes (Diabetes UK) |
| |
|
|
Glycemic
Management of Type 2 Diabetes |
| |
How Tight Is Right and How to Get There (Archives
of Internal Medicine) |
| |
|
|
Cardiovascular
Outcomes in Trials of Oral Diabetes Medications |
| |
Meta-analysis suggested that, compared with
other oral diabetes agents and placebo, metformin was moderately
protective and rosiglitazone possibly harmful, but lack of power
prohibited firmer conclusions (Archives of Internal Medicine) |
| |
|
|
National
Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007 |
| |
Increasingly complex and costly diabetes treatments
are being applied to an increasing population. The magnitude of
these rapid changes raises concerns about whether these more costly
therapies will result in proportionately improved outcomes (Archives
of Internal Medicine) |
| |
|
|
Diabetes
drug costs soaring, top $12B last year |
| |
Americans with diabetes nearly doubled their
spending on drugs for the disease in just six years, with the bill
last year climbing to an eye-popping $12.5 billion (Associated
Press) |
| |
|
|
Researchers
uniting to fight diabetes and heart disease |
| |
Health research and you - Diabetes. 2-page PDF
(Research Australia) |
| |
|
|
Is
a Priming Dose of Insulin Necessary in a Low-Dose Insulin Protocol
for the Treatment of Diabetic Ketoacidosis? |
| |
A priming dose in low-dose insulin therapy in
patients with DKA is unnecessary if an adequate dose of regular
insulin of 0.14 unit · kg body weight–1 · h–1 (about 10 units/h in a 70-kg patient) is given (Diabetes Care) |
| |
|
|
Prandial
Insulin and the Systemic Appearance of Meal-Derived Glucose in
People With Type 1 Diabetes |
| |
Intriguingly, in this issue of Diabetes Care,
Pennant et al. (2) report that the rate of meal-derived glucose
appearance in people with type 1 diabetes is unchanged by administration
of prandial insulin 20 min before meal ingestion (Diabetes Care) |
| |
|
|
Dietary
Energy Density Predicts the Risk of Incident Type 2 Diabetes |
| |
This is the first large population-based prospective
study to report that an energy-dense diet may be associated with
increased risk of development of diabetes, independent of baseline
obesity (Diabetes Care) |
| |
|
|
Pioglitazone-related
insulin sensitivity boost mediates reduced NEFA levels |
| |
The authors suggest that “long-term
administration of pioglitazone may promote reduced NEFA levels
in part by increasing adipose tissue sensitivity to the anti-lipolytic
effects of insulin (Medwire) |
| |
|
|
The
sweeter side of ACE2: Physiological evidence for a role in diabetes |
| |
In this review we will examine the role of the
renin-angiotensin system in the physiopathology and treatment of
diabetes and highlight the potential benefits of the ACE2/Ang-(1-7)/Mas
receptor axis, focusing on recent data about ACE2 (PubMed) |
| |
|
|
Sources
of funding |
| |
If you know of any sources of funding that we
can contact to support the running and future development of Glycosmedia
then please mail Jim Young, Editor-in-Chief jim@glycosmedia.com |
| |
|
